ADR New · CUSIP 900111204 · who reports it, how much, and how much it matters to them
11 of the 720 hedge fund managers we track reported shares of Turkcell Iletisim Hizmetleri a S (NYSE: TKC) on Form 13F for 30 June 2026. Between them they reported USD 44m. The largest position belongs to Two Sigma Investments, at USD 13m. The manager with the most riding on it is Wexford Capital, where it is 0.4% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Two Sigma Investments35 funds on PPLI.com | USD 13m | 0.0% |
| 2 | Millennium Management6 funds on PPLI.com | USD 11m | 0.0% |
| 3 | Renaissance Technologies13 funds on PPLI.com | USD 6.6m | 0.0% |
| 4 | POINT72 Asset Management17 funds on PPLI.com | USD 6.3m | 0.0% |
| 5 | Wexford Capital8 funds on PPLI.com | USD 3.1m | 0.4% |
| 6 | Marshall Wace LLP84 funds on PPLI.com | USD 1.2m | 0.0% |
| 7 | Discerene Group7 funds on PPLI.com | USD 1.2m | 0.1% |
| 8 | Graham Capital Management18 funds on PPLI.com | USD 784,000 | 0.0% |
| 9 | Citadel Advisors32 funds on PPLI.com | USD 761,000 | 0.0% |
| 10 | Aquatic Capital Management3 funds on PPLI.com | USD 434,000 | 0.0% |
| 11 | Voloridge Investment Management6 funds on PPLI.com | USD 192,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Wexford Capital | USD 3.1m | 0.4% |
| 2 | Discerene Group | USD 1.2m | 0.1% |
| 3 | Aquatic Capital Management | USD 434,000 | 0.0% |
| 4 | Graham Capital Management | USD 784,000 | 0.0% |
| 5 | Two Sigma Investments | USD 13m | 0.0% |
| 6 | Renaissance Technologies | USD 6.6m | 0.0% |
| 7 | POINT72 Asset Management | USD 6.3m | 0.0% |
| 8 | Millennium Management | USD 11m | 0.0% |
| 9 | Marshall Wace LLP | USD 1.2m | 0.0% |
| 10 | Voloridge Investment Management | USD 192,000 | 0.0% |
Turkcell Iletisim Hizmetleri a S trades under the symbol TKC on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 900111204.
11 of the 720 hedge fund managers PPLI.com tracks reported Turkcell Iletisim Hizmetleri a S shares on Form 13F for 30 June 2026. The largest reported positions were held by Two Sigma Investments (USD 13m), Millennium Management (USD 11m), Renaissance Technologies (USD 6.6m), POINT72 Asset Management (USD 6.3m) and Wexford Capital (USD 3.1m).
11 managers in our coverage reported it, and between them they run 229 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Wexford Capital, where the position was 0.4% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Turkcell Iletisim Hizmetleri a S or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.